ATE217190T1 - Test und reagentien zur identifizierung von antiproliferierenden stoffen - Google Patents

Test und reagentien zur identifizierung von antiproliferierenden stoffen

Info

Publication number
ATE217190T1
ATE217190T1 AT94919387T AT94919387T ATE217190T1 AT E217190 T1 ATE217190 T1 AT E217190T1 AT 94919387 T AT94919387 T AT 94919387T AT 94919387 T AT94919387 T AT 94919387T AT E217190 T1 ATE217190 T1 AT E217190T1
Authority
AT
Austria
Prior art keywords
cell
cycle
reagents
agent
identifying
Prior art date
Application number
AT94919387T
Other languages
English (en)
Inventor
Giulio Draetta
Guillaume Cottarel
Veronique Damagnez
Original Assignee
Mitotix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitotix Inc filed Critical Mitotix Inc
Application granted granted Critical
Publication of ATE217190T1 publication Critical patent/ATE217190T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
AT94919387T 1993-06-04 1994-06-06 Test und reagentien zur identifizierung von antiproliferierenden stoffen ATE217190T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/073,383 US5443962A (en) 1993-06-04 1993-06-04 Methods of identifying inhibitors of cdc25 phosphatase
PCT/US1994/006365 WO1994028914A1 (en) 1993-06-04 1994-06-06 Assay and reagents for identifying anti-proliferative agents

Publications (1)

Publication Number Publication Date
ATE217190T1 true ATE217190T1 (de) 2002-05-15

Family

ID=22113378

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94919387T ATE217190T1 (de) 1993-06-04 1994-06-06 Test und reagentien zur identifizierung von antiproliferierenden stoffen

Country Status (8)

Country Link
US (2) US5443962A (de)
EP (1) EP0708653B1 (de)
JP (1) JPH08510650A (de)
AT (1) ATE217190T1 (de)
AU (1) AU702174B2 (de)
CA (1) CA2163524C (de)
DE (1) DE69430573T2 (de)
WO (1) WO1994028914A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443962A (en) * 1993-06-04 1995-08-22 Mitotix, Inc. Methods of identifying inhibitors of cdc25 phosphatase
AUPM516994A0 (en) * 1994-04-20 1994-05-12 Gene Shears Pty. Limited An in vivo gene expression system
US6037136A (en) * 1994-10-24 2000-03-14 Cold Spring Harbor Laboratory Interactions between RaF proto-oncogenes and CDC25 phosphatases, and uses related thereto
US5801015A (en) * 1995-06-05 1998-09-01 Mitotix, Inc. Nucleic acid encoding a Candida cell cycle regulatory protein, TYP1 polypeptide
NO953680D0 (no) * 1995-09-18 1995-09-18 Hans Prydz Cellesyklusenzymer
US5972697A (en) * 1995-11-13 1999-10-26 The Salk Institute For Biological Studies NIMA interacting proteins
US7125677B2 (en) * 1995-11-13 2006-10-24 The Salk Institute For Biological Studies NIMA interacting proteins
US5861249A (en) * 1996-04-23 1999-01-19 Cold Spring Harbor Laboratory Assays and reagents for identifying modulators of cdc25-mediated mitotic activation
US6048693A (en) * 1996-10-16 2000-04-11 Bittech, Inc. Phenotypic assays of cyclin/cyclin-dependent kinase function
WO1998018927A1 (en) * 1996-10-30 1998-05-07 National Research Council Of Canada Candida albicans proteins associated with virulence and hyphal formation and uses thereof
WO1998035048A2 (en) 1997-02-07 1998-08-13 Princeton University Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
US6227658B1 (en) * 1997-06-23 2001-05-08 Kabushiki Kaisha Toshiba Apparatus and method for forming thin film using ink-jet mechanism
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
CA2216559A1 (en) * 1997-09-25 1999-03-25 Michel Roberge G2 checkpoint inhibitors and assay
GB9722320D0 (en) * 1997-10-22 1997-12-17 Janssen Pharmaceutica Nv Human cell cycle checkpoint proteins
US6569878B1 (en) * 1997-10-27 2003-05-27 Agouron Pharmaceuticals Inc. Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors
WO1999034806A1 (en) 1998-01-08 1999-07-15 The Regents Of The University Of California KINESIN MOTOR MODULATORS DERIVED FROM THE MARINE SPONGE $i(ADOCIA)
CA2324230A1 (en) * 1998-03-27 1999-09-30 The Scripps Research Institute Kinase wee1 fusion protein compositions, nucleotide sequences, expression systems, and methods of use
DE19860834C1 (de) 1998-12-30 2000-08-24 Albrecht E Sippel Methode zur zellulären High-Throughput-Detektion von nukleären Rezeptor-Liganden-Interaktionen
US6624171B1 (en) * 1999-03-04 2003-09-23 Smithkline Beecham Corporation Substituted aza-oxindole derivatives
GB9904933D0 (en) * 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US6492398B1 (en) 1999-03-04 2002-12-10 Smithkline Beechman Corporation Thiazoloindolinone compounds
US7314926B1 (en) 1999-04-08 2008-01-01 Antisoma Research Limited Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin
US7960540B2 (en) * 1999-04-08 2011-06-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US20080318889A1 (en) * 1999-04-08 2008-12-25 Antisoma Research Limited Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US20080318890A1 (en) * 1999-04-08 2008-12-25 Antisoma Research Limited Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US8114850B2 (en) * 1999-04-08 2012-02-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US6610483B1 (en) * 1999-07-23 2003-08-26 Princeton University Methods for identifying cellular responses attributable to signaling molecule inhibition and inhibitors thereof
WO2001009373A2 (en) * 1999-07-30 2001-02-08 Basf Bioresearch Corporation Native cdc25 substrates, compositions and uses related thereto
AU7366900A (en) * 1999-09-13 2001-04-17 Abbott Gmbh & Co. Kg Methods and compositions for the screening of cell cycle modulators
JP4610828B2 (ja) * 1999-09-22 2011-01-12 株式会社 キャンバス Ｇ２期細胞周期停止の阻害、およびｄｎａ損傷剤に対する細胞感作のための組成物および方法
FR2815347A1 (fr) * 1999-12-14 2002-04-19 Sod Conseils Rech Applic METHODE D'OBTENTION DE LA PHOSPHATASE Cdc25C HUMAINE ET METHODE D'IDENTIFICATION DE MODULATEURS DE LA PHOSPHATASE Cdc25C HUMAINE
US6620818B1 (en) 2000-03-01 2003-09-16 Smithkline Beecham Corporation Method for reducing the severity of side effects of chemotherapy and/or radiation therapy
US6569853B1 (en) * 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
US20050054708A1 (en) * 2003-07-28 2005-03-10 Nichols Matthew James Combinations of drugs for the treatment of neoplasms
US20050080075A1 (en) * 2003-08-25 2005-04-14 Nichols M. James Formulations, conjugates, and combinations of drugs for the treatment of neoplasms
KR100560701B1 (ko) 2003-11-03 2006-03-16 씨제이 주식회사 Ｃｄｃ25Ｂ 포스파타제 과발현 유도가능한 세포주를사용한 ｃｄｃ25Ｂ 억제제 스크리닝 방법
US20050100508A1 (en) * 2003-11-12 2005-05-12 Nichols M. J. Methods for identifying drug combinations for the treatment of proliferative diseases
US20050158320A1 (en) * 2003-11-12 2005-07-21 Nichols M. J. Combinations for the treatment of proliferative diseases
WO2007127002A2 (en) * 2006-03-31 2007-11-08 Cell Signaling Technology, Inc. Protein markers of responsiveness to type iii receptor tyrosine kinase inhibitors
US20090131351A1 (en) * 2007-11-16 2009-05-21 Antisoma Research Limited Methods, compositions, and kits for modulating tumor cell proliferation
KR100887246B1 (ko) 2007-11-22 2009-03-06 건국대학교 산학협력단 예쁜꼬마선충을 이용한 세포주기 조절인자 억제제 스크리닝방법
CN114958609B (zh) * 2022-05-11 2023-10-20 西南民族大学 调控dna复制或修复的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020796A2 (en) * 1991-05-16 1992-11-26 Cold Spring Harbor Laboratory D-type cyclin and uses related thereto
JPH07502164A (ja) * 1991-09-20 1995-03-09 フレッド ハッチンソン キャンサー リサーチ センター ヒトサイクリンｅ
US5262409A (en) * 1991-10-11 1993-11-16 Fred Hutchinson Cancer Research Center Binary tumor therapy
US5294538A (en) * 1991-11-18 1994-03-15 Cold Spring Harbor Labs. Method of screening for antimitotic compounds using the CDC25 tyrosine phosphatase
US5441880A (en) * 1991-11-18 1995-08-15 Cold Spring Harbor Laboratory Human cdc25 genes, encoded products and uses thereof
EP0633933A1 (de) * 1992-03-23 1995-01-18 Imperial Cancer Research Technology Limited Leucin-zipper
US5443962A (en) * 1993-06-04 1995-08-22 Mitotix, Inc. Methods of identifying inhibitors of cdc25 phosphatase

Also Published As

Publication number Publication date
US5443962A (en) 1995-08-22
CA2163524A1 (en) 1994-12-22
EP0708653A4 (de) 1998-11-18
EP0708653B1 (de) 2002-05-08
EP0708653A1 (de) 1996-05-01
WO1994028914A1 (en) 1994-12-22
CA2163524C (en) 2003-04-08
US6251585B1 (en) 2001-06-26
AU702174B2 (en) 1999-02-18
AU7055194A (en) 1995-01-03
DE69430573T2 (de) 2002-11-07
JPH08510650A (ja) 1996-11-12
DE69430573D1 (de) 2002-06-13

Similar Documents

Publication Publication Date Title
ATE217190T1 (de) Test und reagentien zur identifizierung von antiproliferierenden stoffen
DE69522831D1 (de) Assays und vorrichtungen zum nachweis von extrahepatischer biliäreratresie
GR3036073T3 (en) Analytical test apparatus with on board negative and positive control.
ES2054617T3 (es) Nuevo metodo para la deteccion y/o determinacion cuantitativa de agentes ligantes especificos y sus correspondientes sustancias ligables.
CY1111229T1 (el) Μεθοδος προσδιορισμου ρευματοειδους αρθριτιδας με μετρηση αντι-ccp και ιντερλευκλινης 6
BR9710836A (pt) Ensaio de analitos usando marcas em partìculas
DE69530861D1 (de) Vorrichtung zur durchführung eines oder mehrerer kompetitiver immunoassays
DE69838090D1 (de) Mehrgefässplatten mit kleiner störstrahlung für fluoreszenzmessungen von biologischen und biochemischen proben
ES8206856A1 (es) Mejoras en un metodo y su correspondiente equipo de ensayo para determinar antigenos por medio de una reaccion inmuno- quimica
DK0728309T3 (da) Analyseindretninger og fremstilling heraf
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
ES2179081T3 (es) Procedimiento para la deteccion de perturbaciones del sistema de proteina c/proteina s.
ATE333510T1 (de) Enzymatische messung von mycophenolsäure
SI1721162T1 (sl) Postopek za ugotavljanje revmatoidnega artritisa z merjenjem anti-CCP in serumskega amiloida A
ATE243758T1 (de) Testverfahren und testsatz zur diagnose von autoimmunerkrankungen
ES2161011T3 (es) Reactivos para ensayo de ion diazonio y metodos para su utilizacion.
BR9612475A (pt) Método de determinação do estado hepático de uma pessoa incluíndo um beneficiário para transplante de figado
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
Draetta et al. Methods of identifying inhibitors of cdc25 phosphatase
AU2836299A (en) Use of 14-3-3 proteins as sensitive biological markers for detecting pollution caused, inter alia, by polychlorinated biphenyl (pcb) and (xeno)oestrogen and method for quick determination of 14-3-3 proteins
ES2121756T3 (es) Analisis enzimatico y equipo de analisis para medir la activacion celular.
ATE274702T1 (de) Verwendung derivatisierter reagenzien in chemilumineszenz- und elektrochemilumineszenz- nachweisverfahren
BR0215452A (pt) Teste de proteìna tirosina-fosfatase (ptpase) altamente sensitivo com o emprego de 6,8-diflúor-4-metil-umbeliferilfosfato
DE60216482D1 (de) Zusammensetzungen und verfahren zum bestimmen von aa4rp